德琪醫藥-B(06996.HK)擬更換執董及授權代表 2021-05-31T04:09:34-04:00May 31st, 2021| share this article!【財華社訊】德琪醫藥-B(06996.HK)公佈,劉翼騰先生及李甄先生鑒於集團下階段的戰略成長及彼等將投入更多時間於其他工作業務的計劃,已通知董事會彼等有意自董事會退任,且將不會尋求於股東周年大會上(將於2021年6月18日召開)分别獲續任為執行董事及非執行董事。 Read More share this article! Related Posts Japan, EU universities to partner on fostering chip and AI talent May 3rd, 2024 Vietnam’s Galaxy Education eyes up to $20m fundraising to expand footprint May 3rd, 2024 Sony looks to boost film assets with $26bn Paramount acquisition May 3rd, 2024 Soundwill pushes to revalue Causeway Bay site as demand declines May 3rd, 2024